DED-22361-04018
3 vaccinations
6 coded responses
16 check-ins
6 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 150 / PA
- Registered
- 2021-12-03
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-12
Dose 1 — Moderna
-
2021-03-12
Dose 2 — Moderna
-
2021-12-03
Registered in v-safe
-
2021-12-03
Dose 3 — Pfizer-BioNTech
- 2021-12-03
- 2021-12-04
-
2021-12-05
Survey response — days 1–6 daily, dose 3MedDRA: Arthralgia, Chills, Fatigue, Hyperhidrosis, Pre-existing disease — Feeling: Good · Site: Pain · Chills, Joint painsFree text: Yesterday, after i reported, i became fatigued and experienced joint pain as if i was having an arthritis flare up in most of my joints at once. Not having that pain so far today. Chills occured overnight when i woke up in a sweat and left bed.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-06
- 2021-12-07
- 2021-12-08
-
2021-12-09
Survey response — days 1–6 daily, dose 3MedDRA: Night sweats — Feeling: GoodFree text: Night sweatsMedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Survey response — day 7, dose 3MedDRA: Night sweats — Feeling: GoodFree text: Night sweatsMedDRA releases: 2024-11 · check-in free text available
-
2021-12-17
Survey response — day 14, dose 3MedDRA: Headache, Self-medication — Feeling: GoodFree text: Severe headache two days ago. Treated with ibuprofen and was fine until bed. Woke up with no headache.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-24
Survey response — day 21, dose 3MedDRA: Exposure to SARS-CoV-2, SARS-CoV-2 test — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: I waa exposed to covid 12/23/21 · Healthcare visit (other): Covid test at CVS pharmacy in (b)(6), PaMedDRA releases: 2024-11 · check-in free text available
-
2021-12-24
Report sent to call center — day 21, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-12-31
Survey response — day 28, dose 3MedDRA: Exposure to SARS-CoV-2, Headache, Paranasal sinus discomfort, Respiratory tract congestion, SARS-CoV-2 test negative, Upper-airway cough syndrome — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Experienced covid like symptoms. Sinus drip, and pressure, headaches, congestion. All other household members had positive covid tests. I had a negative test.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-07
-
2022-01-07
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-01-14
- 2022-03-04
- 2022-06-03
- 2022-12-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-12 | Moderna | No |
| 2 | 2021-03-12 | Moderna | No |
| 3 | 2021-12-03 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Yesterday, after i reported, i became fatigued and experienced joint pain as if i was having an arthritis flare up in most of my joints at once. Not having that pain so far today. Chills occured overnight when i woke up in a sweat and left bed.
Systemic reaction (other): Night sweats
Release 10 — day 7, dose 3
Systemic reaction (other): Night sweats
Release 10 — day 14, dose 3
Symptoms: Severe headache two days ago. Treated with ibuprofen and was fine until bed. Woke up with no headache.
Release 10 — day 21, dose 3
Symptoms: I waa exposed to covid 12/23/21
Healthcare visit (other): Covid test at CVS pharmacy in (b)(6), Pa
redacted (b)(6)
Release 10 — day 28, dose 3
Symptoms: Experienced covid like symptoms. Sinus drip, and pressure, headaches, congestion. All other household members had positive covid tests. I had a negative test.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | SARS-CoV-2 test | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Arthralgia | · | · | ✓ |
| SRO | Chills | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Hyperhidrosis | · | · | ✓ |
| SRO | Night sweats | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release